This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001 Jan;119(1 Suppl):22S-38S.

doi: 10.1378/chest.119.1_suppl.22s.

Managing oral anticoagulant therapy

J Ansell¹, J Hirsh, J Dalen, H Bussey, D Anderson, L Poller, A Jacobson, D Deykin, D Matchar

Affiliations

PMID: 11157641
DOI: 10.1378/chest.119.1_suppl.22s

Review

Managing oral anticoagulant therapy

J Ansell et al. Chest. 2001 Jan.

. 2001 Jan;119(1 Suppl):22S-38S.

doi: 10.1378/chest.119.1_suppl.22s.

Authors

J Ansell¹, J Hirsh, J Dalen, H Bussey, D Anderson, L Poller, A Jacobson, D Deykin, D Matchar

Affiliation

¹ Department of Medicine, Boston University Medical Center, MA 02118, USA. jack.ansell@bmc.org

PMID: 11157641
DOI: 10.1378/chest.119.1_suppl.22s

No abstract available

PubMed Disclaimer

Similar articles

Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.
Khamashta MA, Hunt BJ. Khamashta MA, et al. J Thromb Haemost. 2005 May;3(5):844-5. doi: 10.1111/j.1538-7836.2005.01405.x. J Thromb Haemost. 2005. PMID: 15869573 No abstract available.
Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.
Rickles FR, Marder VJ. Rickles FR, et al. J Thromb Haemost. 2005 May;3(5):842-3. doi: 10.1111/j.1538-7836.2005.01397.x. J Thromb Haemost. 2005. PMID: 15869572 No abstract available.
Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? Yes.
Scully MF. Scully MF. J Thromb Haemost. 2005 May;3(5):840-1. doi: 10.1111/j.1538-7836.2005.01396.x. J Thromb Haemost. 2005. PMID: 15869571 No abstract available.
[Monitoring of anticoagulation--management in practice].
Schinzel H, Weilemann LS. Schinzel H, et al. Dtsch Med Wochenschr. 2014 Jan;139 Suppl 1:S27-30. doi: 10.1055/s-0033-1359975. Epub 2014 Jan 20. Dtsch Med Wochenschr. 2014. PMID: 24446039 Review. German. No abstract available.
Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome.
Sciascia S, Lopez-Pedrera C, Cecchi I, Pecoraro C, Roccatello D, Cuadrado MJ. Sciascia S, et al. Rheumatology (Oxford). 2016 Oct;55(10):1726-35. doi: 10.1093/rheumatology/kev445. Epub 2016 Feb 3. Rheumatology (Oxford). 2016. PMID: 26843482 Review.

See all similar articles

Cited by

Resistance to oral vitamin K for reversal of overanticoagulation during Crohn's disease relapse.
Fugate SE, Ramsey AM. Fugate SE, et al. J Thromb Thrombolysis. 2004 Jun;17(3):219-23. doi: 10.1023/B:THRO.0000040492.02376.cc. J Thromb Thrombolysis. 2004. PMID: 15353921
Clinical Model for Predicting Warfarin Sensitivity.
Ma Z, Cheng G, Wang P, Khalighi B, Khalighi K. Ma Z, et al. Sci Rep. 2019 Sep 6;9(1):12856. doi: 10.1038/s41598-019-49329-0. Sci Rep. 2019. PMID: 31492893 Free PMC article.
Reliability, validity and ease of use of a portable point-of-care coagulation device in a pharmacist-managed anticoagulation clinic.
Lizotte A, Quessy I, Vanier MC, Martineau J, Caron S, Darveau M, Dubé A, Gilbert E, Blais N, Lalonde L. Lizotte A, et al. J Thromb Thrombolysis. 2002 Dec;14(3):247-54. doi: 10.1023/a:1025061129122. J Thromb Thrombolysis. 2002. PMID: 12913406
A clinical study of genetic testing to guide the dosing of warfarin after heart valve replacement.
Zhang F, Zhang C, Gu C, Yu Y, Li J. Zhang F, et al. BMC Cardiovasc Disord. 2022 Apr 19;22(1):183. doi: 10.1186/s12872-022-02620-x. BMC Cardiovasc Disord. 2022. PMID: 35439929 Free PMC article.
Treatment of coagulopathy in intracranial hemorrhage.
Aguilar MI, Freeman WD. Aguilar MI, et al. Curr Treat Options Neurol. 2010 Mar;12(2):113-28. doi: 10.1007/s11940-010-0061-1. Curr Treat Options Neurol. 2010. PMID: 20842575

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information